跳至主要内容
临床试验/NCT05063396
NCT05063396招募中不适用

The Efficacy and Safety of Opioid-free Anesthesia(OFA) for Non-small-cell Lung Cancer Resection and Its Underlying Clinical Value: a Prospective Study

Shanghai Zhongshan Hospital2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2021年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
60
试验地点
2
主要终点
acute postoperative pain scores

研究概览

简要总结

to investigate the efficacy and safety of opioid-free anesthesia for non-small-cell lung cancer resection and its underlying clinical value

详细描述

Opioids used to have its irreplaceable role in standard opioid-based anesthesia, yet with the help of hypnotics, local anesthetics, anti-inflammatory drugs, α-2 agonists and epidural techniques, opioid-free anesthesia (OFA) has been proved to be safe and feasible for non-cardiac major surgeries. Opioid-sparing anesthesia (OSA) is encouraged by the needs of enhanced recovery and recommended by the latest guidelines for anesthesia of lung surgery. According to previous studies, both opioid-sparing and opioid-free anesthesia would reduce the incidence of opioid-related adverse events and speed up the postoperative recovery to some extent, yet no studies ever are dedicated to compare these two different techniques.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • going through thoracoscopic lung surgery including lobectomy, segmentectomy, single or multiple wedge resection, and two of the above procedures combined;
  • able to complete the pain scoring face-to-face;
  • no cognitive dysfunction or history of anesthetic drug allergy;
  • ASA grade I-II

排除标准

  • psychological disorders

结局指标

主要结局

acute postoperative pain scores

时间窗: day2 postoperation

visual analog scale was used

occurrence of postoperative opioid-related adverse events

时间窗: day2 postoperation

occurrence of postoperative opioid-related adverse events

次要结局

  • Pathologic results and TNM rating(within one month)
  • occurrence of episodes of postoperative pain (VAS ≥4)(within 48hours)
  • PCEA bolus consumption(within 48hours)
  • need for rescue intravenous opioids or any type of painkiller(within 48hours)
  • hospital length of stay and total hospital expenses(within 10days)
  • relapse free survival and overall survival(within 5 years)

研究者

发起方
Shanghai Zhongshan Hospital
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验